UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 10 | October 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 12
December-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2412675


Registration ID:
552867

Page Number

g662-g678

Share This Article


Jetir RMS

Title

NANOSTRUCTURED LIPID CARRIER - A LIPID BASED NOVEL DRUG DELIEVERY TOOL

Abstract

Nanostructured Lipid Carriers (NLCs) are advanced drug delivery systems designed to overcome the limitations of conventional drug delivery methods, including poor solubility, instability, and inefficient bioavailability. NLCs are second-generation lipid nanoparticles, composed of a blend of solid and liquid lipids stabilized by surfactants. This unique composition enables the formation of a matrix with increased drug loading capacity, enhanced stability, and controlled drug release properties. The biocompatibility and biodegradability of lipids used in NLCs make them a promising carrier for a wide range of therapeutic agents, including hydrophilic and hydrophobic drugs, peptides, and even genetic materials. Their small particle size, typically in the nanometer range, facilitates improved penetration across biological membranes, allowing for targeted and sustained drug delivery. NLCs also offer advantages in protecting sensitive drugs from degradation and reducing adverse side effects. Recent advancements have demonstrated the versatility of NLCs in various applications, including oral, topical, transdermal, pulmonary and parenteral drug delivery. Additionally, NLCs have shown potential in addressing challenges in cancer therapy, central nervous system disorders, and antimicrobial treatments. Emerging research emphasizes their role in enhancing bioavailability and patient compliance, particularly in challenging therapeutic scenarios. This review explores the structure, preparation techniques, advantages, and applications of NLCs in modern pharmaceutical sciences, highlighting their role as a novel and efficient drug delivery tool with significant potential to revolutionize personalized medicine and therapeutic outcome.

Key Words

NLC , nanoparticles , solid lipid nanoparticles

Cite This Article

"NANOSTRUCTURED LIPID CARRIER - A LIPID BASED NOVEL DRUG DELIEVERY TOOL", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 12, page no.g662-g678, December-2024, Available :http://www.jetir.org/papers/JETIR2412675.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"NANOSTRUCTURED LIPID CARRIER - A LIPID BASED NOVEL DRUG DELIEVERY TOOL", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 12, page no. ppg662-g678, December-2024, Available at : http://www.jetir.org/papers/JETIR2412675.pdf

Publication Details

Published Paper ID: JETIR2412675
Registration ID: 552867
Published In: Volume 11 | Issue 12 | Year December-2024
DOI (Digital Object Identifier):
Page No: g662-g678
Country: Malegaon Dist- Washim, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000255

Print This Page

Current Call For Paper

Jetir RMS